SPARC files draft paper to raise up to Rs 250 crore through rights issue

22 Sep 2015 Evaluate

Sun Pharma Advanced Research Company (SPARC) has filed draft papers with markets regulator Securities and Exchange Board of India (SEBI) to raise up to Rs 250 crore through a rights issue. Ernst & Young Merchant Banking Services, Inga Capital are the lead managers to the issue.

The company will issue equity shares aggregating up to Rs 25,000 lakh to its existing equity shareholders on a rights basis. The proceed of the issue will be utilized for meeting costs related to pharmaceutical research and development, clinical trials and for other general corporate purposes.

Sun Pharma Advanced Research Company is an international pharmaceutical company engaged in research and development of drugs and delivery systems.


Sun Pharma Adv. Res Share Price

134.05 -1.55 (-1.14%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 654.25
Indegene 520.25
CMS Info Systems 344.60
Sagility 52.62
Smartworks Coworking 468.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×